Medrobotics nets $2.4m, looks for another $22.6m

Medrobotics has raised $2.4 million in a new round of equity financing, and looks to raise another $22.6 million, according to an SEC filing posted last week.

Medrobotics produces the Flex robotic endoscope system. The Flex system uses a flexible robotic endoscope, a range of flexible instruments and a high-definition vision system for use in accessing and visualizing structures in the mouth and throat, Raynham, Mass.-based Medrobotics said.

The round was joined by 9 anonymous investors, according to the filing, but no details or investment amounts have been released.

In July, Medrobotics said it won FDA 510(k) clearance for its Flex robotic transoral surgery system and is launching the system in the U.S.

Last July, Medrobotics celebrated the world’s 1st cancer surgeries performed with its Flex surgical robot in a pair of procedures conducted at a hospital in Germany. Surgeons used the Flex system to successfully remove lesions from a pair of patients, effectively launching Medrobotics’ postmarket clinical trial, which will enroll up to 80 patients in Germany and Belgium.

The Flex system won CE Mark approval in the European Union last March.

The post Medrobotics nets $2.4m, looks for another $22.6m appeared first on MassDevice.

from MassDevice http://ift.tt/1GncSIJ